We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-9 of 9

EU, UK: CJEU opinion delivered on the Specific Mechanism

  • Hogan Lovells
  • -
  • European Union, United Kingdom
  • -
  • October 23 2014

Advocate General Niilo Jääskinen’s opinion on the interpretation of the Specific Mechanism (in the case of Merck v Sigma (Case C-53913) was

English court asks the CJEU to try again on supplementary protection certificates

  • Hogan Lovells
  • -
  • European Union, United Kingdom
  • -
  • October 25 2012

Following two recent decisions of the English High Court, preliminary references have been made to the European Court of Justice seeking clarity on when a supplementary protection certificate can be granted for pharmaceutical products comprising combinations of active ingredients

EPO patent examination guidelines to reflect stem cells ruling

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 20 2012

The European Patent Office (EPO)'s latest revisions to the Guidelines for Examination (in force on 20 June 2012) now reflect the Brüstle ruling of the Court of Justice (CJEU) on the patentability of stem cell inventions using human embryos

CJEU confirms the availability of negative term Supplementary Protection Certificates ("SPCs") in Januvia case

  • Hogan Lovells
  • -
  • European Union
  • -
  • December 8 2011

The Court of Justice of the European Union (CJEU) gave its decision in the Januvia case today, 8 December 2011

CJEU provides some clarification on supplementary protection certificates ("SPCs") and combination products in Medeva and Georgetown cases

  • Hogan Lovells
  • -
  • European Union
  • -
  • November 24 2011

The Court of Justice of the European Union (CJEU) gave its opinion on the Medeva and Georgetown cases today, 24 November 2011

Ban on embryonic stem cell patenting in Europe Court of Justice rules on meaning of "human embryo" in stem cells debate

  • Hogan Lovells
  • -
  • European Union, Germany
  • -
  • October 25 2011

The Court of Justice of the European Union (CJEU) handed down its long-awaited judgment in the Brüstle case on the patentability of stem cell inventions

Supplementary protection certificates: can a negative lead to something positive?

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 21 2011

Ever since the introduction of the Pediatric Regulation the question of whether it is permissible to grant a negative or zero term Supplementary Protection Certificate (SPC) has been controversial, with a range of inconsistent decisions across the EU

European court upholds Commission case against AstraZeneca relating to Losec, but reduces fine

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 16 2010

On 1 July 2010, the General Court of the European Union (the "General Court") handed down its eagerly awaited judgment in relation to AstraZeneca's appeal against a 2005 decision of the European Commission (the "Commission") finding that AstraZeneca had abused its dominant position by blocking or delaying generic versions of its drug Losec

European Commission issues first report on patent settlements

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 16 2010

On 5 July 2010, the European Commission (the "Commission") published its first report on its monitoring of patent settlements in the pharmaceutical sector (the "Report"